Kugelmeiers Ltd

IMAGINE.A future for our children and grandchildren, whose medical care is governed and guided by health and not disease: safe stem cell treatments and regenerative therapies that heal and save lives. Accessible and humane to everyone. The anxiety and worry before major and risky interventions are removed. We have dedicated ourselves to this regenerative medicine - ethical, responsible, visionary & passionate. The development of our shared future has begun: In 2019, we will start modifying islet transplantation in humans to treat diabetes. HUMAN FIRST Kugelmeiers Ltd. is a Spin-off company from the University of Zurich, Switzerland with a team of medical, research and transplant specialists and serial entrepreneurs. Our aim: stem cell therapies for future medical applications.